Pierre Fabre, French pharmaceutical and dermocosmetics group

3,1BN€

Revenue in 2024

220M€

Invested in R&D

+10 200

Employees

43

Locations

les éléments du labo scientifique

Discover

Our Brands

Our dual expertise - pharmaceutical and dermo-cosmetic - helps us offer a holistic approach to care: prevent, treat and support.

Learn more about our brands

une fille avec un visage magnifique, peau jolie

Taking care of your skin, hair and oral health.

l'attention d'une fille vers un patient qui atteint le cancer

Treating cancer

Une infirmière qui accompagne une patiente

Treating chronic diseases

un professionnel de santé prend soin d'une petite patiente

Treating everyday ailments

Focus on

Our Commitments

Green Mission Pierre Fabre is the eco-socio-responsible commitment from the Pierre Fabre Group, awarded the Committed to CSR by AFNOR Certification at the Exemplary level. Thanks to our conviction and drive, we use sustainable innovation to benefit Nature and People, focusing on 4 issues:

Discover all our commitments

Innovate

Innovate sustainably

Innovate : sustainably by taking our inspiration from nature, thanks to our botanical expertise and the development of eco-extraction

Protect

Protect our plant heritage

reduce our environmental footprint, promote organic farming and encourage agro-ecology

Respect

Respect the farmers and harvesterss

We respect the farmers and harvesters we work with, and help develop the regions from which we source our ingredients

Guarantee

Guarantee the quality

of our eco-designed products, and maximize the development of Ecocert Organic certified active ingredients and our ethical practices

les collaboratrices heureuses

Looking for a company

that is in line with your values?

Joining the Pierre Fabre Group means entering a company with a history overflowing with values, innovation and expertise for patients and consumers. What are you waiting for? Look at our offers, apply and embark on a human adventure !

Discover our job offers

Our latest

News

Curious to learn more about our news? Get the latest on our brand innovations, our flagship commitments and the highlights of the life of the group

Marie-Andrée Gmache

Marie-Andrée GAMACHE joins Pierre Fabre Laboratories as CEO of the Medical Care

Castres (France), March 31, 2025 – Pierre Fabre Laboratories has announced the appointment of Marie-Andrée Gamache as Chief Executive Officer (CEO) of its Medical Care. In this capacity, Marie-Andrée Gamache joins the Group’s Executive Committee and reports to Eric

Fernando Junoy Nomincation chez les Laboratoires Pierre Fabre

31 October 2024

Fernando Junoy nommé Directeur de la Business Unit Internationale des Laboratoires Pierre Fabre

Castres, le 31 octobre 2024 – Les Laboratoires Pierre Fabre annoncent la nomination de Fernando Junoy au poste de Directeur de leur Business Unit Internationale (BUI). À ce titre, il est rattaché à Eric Ducournau, Directeur général, et rejoint le Comité de direction.

Les Laboratoires Pierre Fabre obtiennent le plus haut niveau du label Numérique Responsable

Pierre Fabre Laboratories Awarded Responsible Digital Label

May 16, 2024 – Pierre Fabre Laboratories has been awarded the highest level of the Digital Responsibility label for its commitment to a more environmentally and socially responsible digital industry.

un petit garçon assis sur le genou de Papa fait un check avec une docteur

Global study on rosacea: 5% of the population affected, according to Pierre Fabre Laboratories.

Spotlight on rosacea, which affects 5% of the world population according to the first global epidemiological study of this dermatosis carried out by Pierre Fabre Laboratories.

un petit garçon assis sur le genou de Papa fait un check avec une docteur

Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne”

Published in February 2024 in the Journal of American Academy of Dermatology (JAAD), this study reveals the prevalence of acne worldwide in a completely new light.

logos des Kinnate et Laboratoires Pierre Fabre

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories

•    Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.

Herver HOPPENNOT

10 January 2024

Hervé Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories

Castres (France), January 5th, 2024 – President and CEO of the biotechnology company Incyte since 2014, Hervé Hoppenot will bring his extensive pharmaceutical expertise to the Board of Directors of Pierre Fabre Laboratories, particularly in the field of

FORBES 2023 MEILLEUR EMPLOYEUR

13 October 2023

PIERRE FABRE CONFIRMED AS ONE OF THE WORLD’S BEST EMPLOYERS

For the 3rd year in a row, Pierre Fabre Laboratories is proud to be listed in the World’s Best Employers ranking. This ranking, compiled by the American magazine FORBES and the independent German market research firm Statista, places Pierre Fabre at Top 6 among cosmetic companies and Top 7 among pharmaceutical companies.   This year, Pierre Fabre has moved up another 7 places in the overall ranking, rising to the 111th position out of the 800 companies selected (118th place in 2022) and placing amongthe Top 20 French companies.    To compile this best employers ranking, Statista surveyed 170,000 employees from more than 50 countries working for multinational companies and institutions. The questionnaire covered various aspects such as corporate impact and image, talent development, gender equality and social responsibility. 

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.

Get in touch with your local Pierre Fabre branch

International FR EN

Europe

America

Asia

China

Oceania

Australia